Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Sci Food Agric ; 96(9): 2998-3006, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26399367

RESUMO

BACKGROUND: Deferriferrichrysin (Dfcy) is a siderophore found in foods fermented by Aspergillus oryzae and is a promising candidate for an antioxidant food additive because of its high binding constant toward iron. However, the Dfcy concentration is typically low in foods and cultures. RESULTS: We optimised culture conditions to improve Dfcy production to 2800 mg L(-1) from 22.5 mg L(-1) under typical conditions. Then, we evaluated the potential of Dfcy as a food additive by measuring its safety, stability, and antioxidant activity. Dfcy was sufficiently stable that over 90% remained after pasteurisation at 63 °C for 30 min at pH 3-11, or after sterilisation at 120 °C for 4 min at pH 4-6. Dfcy showed high antioxidant activity in an oil-in-water model, where inhibition of lipid oxidation was measured by peroxide value (PV) and thiobarbituric acid reactive substances (TBARS) assays. Dfcy decreased PV and TBARS by 83% and 75%, respectively. Antioxidant activity of Dfcy was equal to or higher than that of the synthetic chelator EDTA. CONCLUSION: Our study provides the first practical method for production of Dfcy. Dfcy can be a novel food-grade antioxidant and the first natural alternative to the synthesised iron chelator EDTA. © 2015 Society of Chemical Industry.


Assuntos
Antioxidantes/isolamento & purificação , Aspergillus oryzae/química , Conservantes de Alimentos/isolamento & purificação , Quelantes de Ferro/isolamento & purificação , Modelos Químicos , Peptídeo Hidrolases/metabolismo , Peptídeos Cíclicos/isolamento & purificação , Animais , Antioxidantes/efeitos adversos , Antioxidantes/química , Antioxidantes/economia , Aspergillus oryzae/crescimento & desenvolvimento , Aspergillus oryzae/metabolismo , Fermentação , Conservantes de Alimentos/efeitos adversos , Conservantes de Alimentos/química , Conservantes de Alimentos/economia , Indústria de Processamento de Alimentos/economia , Proteínas Fúngicas/metabolismo , Temperatura Alta/efeitos adversos , Resíduos Industriais/análise , Resíduos Industriais/economia , Quelantes de Ferro/efeitos adversos , Quelantes de Ferro/química , Quelantes de Ferro/economia , Japão , Testes de Mutagenicidade , Oryza/química , Peptídeos Cíclicos/efeitos adversos , Peptídeos Cíclicos/química , Peptídeos Cíclicos/economia , Proteínas de Vegetais Comestíveis/química , Proteínas de Vegetais Comestíveis/economia , Proteínas de Vegetais Comestíveis/isolamento & purificação , Proteínas de Vegetais Comestíveis/metabolismo , Hidrolisados de Proteína/química , Hidrolisados de Proteína/economia , Hidrolisados de Proteína/isolamento & purificação , Hidrolisados de Proteína/metabolismo , Saccharomyces cerevisiae/crescimento & desenvolvimento , Saccharomyces cerevisiae/metabolismo , Sementes/química , Testes de Toxicidade Aguda , Vinho/análise , Vinho/microbiologia
2.
Int J Vitam Nutr Res ; 77(1): 13-21, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17685091

RESUMO

Ferrichrysin (Fcy), which is produced by Aspergillus oryzae and is present in foods used for human consumption, belongs to a group of hydroxamate siderophore ferric iron chelators. Fcy (100 mg/mL) dissolves completely at both pH 2.0 and 7.0, being very stable at a wide range of pH, high temperatures and pressures, with little reactivity to dietary iron absorption inhibitors, phytic acid, tannic acid, and catechin. We studied the effect of Fcy in male Sprague-Dawley rats with iron-deficiency anemia, which were separated into three different dietary groups (n=5) and supplementing diets as follows: (i) ferric citrate, (ii) heme iron concentrate, and (iii) Fcy (35 mg Fe/kg diet) for three weeks. Fcy exhibited the same beneficial effect in improving iron deficiency anemia as ferric citrate, being significantly greater than the effect of heme iron. The iron concentration of liver in the Fcy group was 35% greater than that in the ferric citrate group. These findings indicate that Fcy could be an efficient oral iron supplement to prevent or treat iron deficiency.


Assuntos
Anemia Ferropriva/tratamento farmacológico , Ferricromo/análogos & derivados , Animais , Suplementos Nutricionais , Compostos Férricos/administração & dosagem , Ferricromo/administração & dosagem , Ferricromo/química , Heme/química , Concentração de Íons de Hidrogênio , Ferro/administração & dosagem , Ferro/análise , Ferro/sangue , Fígado/química , Masculino , Ratos , Ratos Sprague-Dawley , Solubilidade , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...